AMBER BRASFIELD: Open Payments
NPI 1821584673 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 29 payments from 7 companies in 2025. Trend: 2023 $1,503 · 2024 $949 · 2025 $951
Food & beverage: $851Education: $100
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 2 | $340 |
| Janssen Biotech, Inc. | 13 | $330 |
| QOL Medical, LLC | 6 | $115 |
| Madrigal Pharmaceuticals | 4 | $96 |
| Novo Nordisk Inc | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: TREMFYA, Sucraid, REZDIFFRA, Wegovy, Saxenda, ENTYVIO, RINVOQ.
Industry payments across MS — which companies pay providers there.
